BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20823234)

  • 1. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
    Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.
    Yeh CH; Bellon M; Pancewicz-Wojtkiewicz J; Nicot C
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6731-6. PubMed ID: 27247421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased
    Bellon M; Nicot C
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.
    Palomero T; Ferrando A
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S205-10. PubMed ID: 19778842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
    O'Neil J; Grim J; Strack P; Rao S; Tibbitts D; Winter C; Hardwick J; Welcker M; Meijerink JP; Pieters R; Draetta G; Sears R; Clurman BE; Look AT
    J Exp Med; 2007 Aug; 204(8):1813-24. PubMed ID: 17646409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase.
    Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim HY; Ahn JS; Kim SM; Kim MY; Hong JA; Seo MS; Lang F; Choi EJ; Park HS
    J Cell Sci; 2011 Jan; 124(Pt 1):100-12. PubMed ID: 21147854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells.
    Bellon M; Moles R; Chaib-Mezrag H; Pancewicz J; Nicot C
    J Hematol Oncol; 2018 Sep; 11(1):119. PubMed ID: 30231940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.
    Thompson BJ; Buonamici S; Sulis ML; Palomero T; Vilimas T; Basso G; Ferrando A; Aifantis I
    J Exp Med; 2007 Aug; 204(8):1825-35. PubMed ID: 17646408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.
    Yu P; Petrus MN; Ju W; Zhang M; Conlon KC; Nakagawa M; Maeda M; Bamford RN; Waldmann TA
    Leukemia; 2015 Mar; 29(3):556-66. PubMed ID: 25118879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
    Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
    Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-secretase inhibitor does not induce cytotoxicity in adult T-cell leukemia cell lines despite NOTCH1 expression.
    Suzuki S; Hourai S; Uozumi K; Uchida Y; Yoshimitsu M; Miho H; Arima N; Ueno SI; Ishitsuka K
    BMC Cancer; 2022 Oct; 22(1):1065. PubMed ID: 36243685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
    van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Notch1 signaling by HTLV-1 Tax promotes proliferation of adult T-cell leukemia cells.
    Cheng W; Zheng T; Wang Y; Cai K; Wu W; Zhao T; Xu R
    Biochem Biophys Res Commun; 2019 May; 512(3):598-603. PubMed ID: 30914196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
    Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
    Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
    Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
    Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
    Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
    J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL.
    Sulis ML; Williams O; Palomero T; Tosello V; Pallikuppam S; Real PJ; Barnes K; Zuurbier L; Meijerink JP; Ferrando AA
    Blood; 2008 Aug; 112(3):733-40. PubMed ID: 18411416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.